E-LIB Suche - Ergebnisse für: Park, Margriet V. D. Z.

1

Options for imaging cellular therapeutics in vivo: a multi-..:

Helfer, Brooke M. ; Ponomarev, Vladimir ; Patrick, P. Stephen...
Cytotherapy. 23 (2021) 9 - p. 757-773 , 2021

2

Options for imaging cellular therapeutics in vivo: a multi-..:

Helfer, Brooke M ; Ponomarev, Vladimir ; Patrick, P. Stephen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344904/. , 2021

Link: http://www.ncbi.nlm.nih...

3

Options for imaging cellular therapeutics in vivo:a multi-s..:

Helfer, Brooke M ; Ponomarev, Vladimir ; Patrick, P. Stephen...
Helfer , B M , Ponomarev , V , Patrick , P S , Blower , P J , Feitel , A , Fruhwirth , G O , Jackman , S , Pereira Mouriès , L , Park , M V D Z , Srinivas , M , Stuckey , D J , Thu , M S , van den Hoorn , T , Herberts , C A & Shingleton , W D 2021 , ' Options for imaging cellular therapeutics in vivo : a multi-stakeholder perspective ' , CYTOTHERAPY , vol. 23 , no. 9 , pp. 757-773 . https://doi.org/10.1016/j.jcyt.2021.02.005. , 2021

Link: https://kclpure.kcl.ac.u..

4

Options for imaging cellular therapeutics in vivo:a multi-s..:

Helfer, Brooke M ; Ponomarev, Vladimir ; Patrick, P. Stephen...
Helfer , B M , Ponomarev , V , Patrick , P S , Blower , P J , Feitel , A , Fruhwirth , G O , Jackman , S , Pereira Mouriès , L , Park , M V D Z , Srinivas , M , Stuckey , D J , Thu , M S , van den Hoorn , T , Herberts , C A & Shingleton , W D 2021 , ' Options for imaging cellular therapeutics in vivo : a multi-stakeholder perspective ' , CYTOTHERAPY , vol. 23 , no. 9 , pp. 757-773 . https://doi.org/10.1016/j.jcyt.2021.02.005. , 2021

Link: https://kclpure.kcl.ac.u..

5

A critical review of the factors determining dermal absorpt..:

Marquart, Hans ; Park, Margriet V.D.Z ; Giannakou, Christina... , 2020

Link: https://data.europa.eu/d..

6

Nonclinical regulatory immunotoxicity testing of nanomedici..:

Giannakou, Christina ; Park, Margriet V. D. Z. ; Bosselaers, Irene E. M....
WIREs Nanomedicine and Nanobiotechnology. 12 (2020) 5 - p. , 2020

Link: https://doi.org/10.1002/..

7

Nonclinical regulatory immunotoxicity testing of nanomedici..:

Giannakou, Christina ; Park, Margriet V. D. Z ; Bosselaers, Irene E. M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507198/. , 2020

Link: http://www.ncbi.nlm.nih...

8

Nonclinical regulatory immunotoxicity testing of nanomedici..:

Giannakou, Christina ; Park, Margriet V. D. Z ; Bosselaers, Irene E. M...
Giannakou , C , Park , M V D Z , Bosselaers , I E M , de Jong , W H , van der Laan , J W , van Loveren , H , Vandebriel , R J & Geertsma , R E 2020 , ' Nonclinical regulatory immunotoxicity testing of nanomedicinal products : Proposed strategy and possible pitfalls ' , Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology , vol. 12 , no. 5 , 1633 . https://doi.org/10.1002/wnan.1633. , 2020

Link: https://cris.maastrichtu..

9

Systematic selection of a dose metric for metal-based nanop..:

Verschoor, Anja J. ; Harper, Stacey ; Delmaar, Christiaan J.E....
NanoImpact. 13 (2019) - p. 70-75 , 2019

Link: https://doi.org/10.1016/..

10

Considerations for Safe Innovation: The Case of Graphene:

Park, Margriet V.D.Z. ; Bleeker, Eric A.J. ; Brand, Walter...
ACS Nano. 11 (2017) 10 - p. 9574-9593 , 2017

Link: https://doi.org/10.1021/..

11

Considerations for Safe Innovation: The Case of Graphene:

Park, Margriet V D Z ; Bleeker, Eric A J ; Brand, Walter...
1936-0851. , 2017

Link: https://dspace.library.u..

12

Nanomedicinal products:a survey on specific toxicity and si..:

Brand, Walter ; Noorlander, Cornelle W ; Giannakou, Christina...
Brand , W , Noorlander , C W , Giannakou , C , De Jong , W H , Kooi , M W , Park , M V D Z , Vandebriel , R J , Bosselaers , I E M , Scholl , J H G & Geertsma , R E 2017 , ' Nanomedicinal products : a survey on specific toxicity and side effects ' , International Journal of Nanomedicine , vol. 12 , pp. 6107-6129 . https://doi.org/10.2147/IJN.S139687. , 2017

Link: https://cris.maastrichtu..

13

Dose metric for the prediction of toxicity of nanomaterials:

Cassee, Flemming R. ; Braakhuis, Hedwig M. ; Park, Margriet V....
Toxicology Letters. 258 (2016) - p. S23 , 2016

Link: https://doi.org/10.1016/..

14

A comparison of immunotoxic effects of nanomedicinal produc..:

Giannakou, Christina ; Park, Margriet V. D. Z ; de Jong, Wim H...
Giannakou , C , Park , M V D Z , de Jong , W H , van Loveren , H , Vandebriel , R J & Geertsma , R E 2016 , ' A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements ' , International Journal of Nanomedicine , vol. 11 , pp. 2935-2952 . https://doi.org/10.2147/IJN.S102385. , 2016

Link: https://cris.maastrichtu..

15

PALB2, CHEK2 and ATM rare variants and cancer risk:data fro..:

Southey, M. C. (Melissa C.) ; Goldgar, D. E. (David E.) ; Winqvist, R. (Robert)...
info:eu-repo/semantics/altIdentifier/pissn/0022-2593. , 2016

Link: http://urn.fi/urn:nbn:fi..